 |
|
|
| |
Long term outcome among HCV-infected people who use drugs (PWUD) successfully treated for HCV infection with Glecaprevir/ Pibrentasvir (G/P)
|
| |
| |
EASL 2024 June 5-8 Milan Italy
Brian Conway1,2, Rossitta Yung1, Shawn Sharma3, Shana Yi4, Saina Beitari4. 1Vancouver Infectious Diseases Centre, Vancouver,
Canada; 2Simon Fraser University, Burnaby, Canada; 3Vancouver Infectious Diseases Centre, Vancouver, Canada; 4Vancouver Infectious Diseases Centre, Vancouver, Canada
|
| |
|
|
|
|
|
